Sarah Cannon Research Institute (SCRI) is a research organization focused on therapy for patients including drug development. With corporate headquarters in Nashville, Tennessee, USA, he conducts community-based clinical trials in oncology, cardiology, gastroenterology and other therapeutic areas. The current CEO is Dee Anna Smith.
SCRI produced more than 2,500 patients for cancer trials in 2009, including more than 500 to phase I studies. Non-oncology experiments accounted for nearly 1,500 additional patients for a total of nearly 4,000.
The drug development program has performed the first "70 in human trials". SCRI has been involved in the testing and development of about 10 drugs that have been approved since 1999.
SCRI employs more than 350 people and No. 4 on the 2010 Top 10 NashvillePost Magazine list in Middle Tennessee. In 2009 and 2010, SCRI earned a place on the Modern Healthcare list of the 100 Best Places to Work in Health Care.
Video Sarah Cannon Research Institute
History
SCRI was formed in 2004 through a joint venture between Tennessee Oncology and HCA. Before helping to shape SCRI, Tennessee Oncology has been conducting research on behalf of the Minnie Pearl Research Network since 1993.
SCRI started a cardiovascular initiative in 2008. Currently, there are three strategic locations for cardiovascular research: Redmond Regional Medical Center in Rome, Georgia, Centennial Heart in Nashville, Tennessee, and Osceola Regional Medical Center in Kissimmee, Florida.
Global Services Division was created in 2010 to provide project management, clinical monitoring, data management, biostatistics, security, medical writing, quality assurance and data security monitoring boards on a global platform.
Maps Sarah Cannon Research Institute
Headquarters
SCRI headquarters are in Nashville, Tennessee, United States. Its multi-specialty division is based in Memphis, Tennessee. Sarah Cannon Research UK is headquartered in London, England.
Other locations
SCRI works with 57 sites in 24 states and the UK. These include six strategic oncology sites and 11 multi-specialty strategic sites.
Oncology strategic sites include:
- Tennessee Oncology, Nashville, Tennessee
- Florida Cancer Specialist, Fort Myers, Florida
- Oncology Hematology Treatment, Cincinnati, Ohio
- Association of Oncology and Hematology Chattanooga, Chattanooga, Tennessee
- The South Carolina Oncology Association, Columbia, South Carolina
- Virginia Cancer Institute, Richmond, Virginia
Multi-specialty strategic sites include:
- The Gastroenterology Group of Memphis, Memphis, Tennessee
- Gastrointestinal Nurses, Jackson, Mississippi
- Frist Clinic - Nashville Gastroenterology, Nashville, Tennessee
- Digestive Health Specialist, Tupelo, Mississippi
- Centennial Heart, Nashville, Tennessee
- Redmond County Hospital, Harbin Clinic, Rome, Georgia
- SCRI Research Center, Germantown, Tennessee
- Jackson Clinic, Jackson, Tennessee
- Gynecology & amp; Obstetrics, Memphis, Tennessee
- Women Clinic, Ft. Collins, Colorado
- Eastern Dermatology, Germantown, Tennessee
References
External links
- Sarah Cannon Research Institute
Source of the article : Wikipedia
0 Comments